Category: Healthcare Industry

Exercise Often Declines After Cancer Diagnosis

… to help cancer patients maintain their physical activity are rare. “There need to be more exercise programs within health centers and in gyms to provide cancer patients with guidance to help them remain physically active,” Mao said. “Physical …

Exercise Often Declines After Cancer Diagnosis

… to help cancer patients maintain their physical activity are rare. “There need to be more exercise programs within health centers and in gyms to provide cancer patients with guidance to help them remain physically active,” Mao said. “Physical …

Philips and Banner Health Sign 15-Year Agreement to Extend Successful …

Philips and Banner Health Sign 15-Year Agreement to Extend Successful Connected Healthcare Programs, Transforming Care and Lowering Costs, While Improving Quality Royal Philips a leading health technology company, and Arizona-based Banner Health, today announced a multi-year partnership intended to further innovate and expand on their successful joint connected healthcare programs such as the Intensive Ambulatory Care pilot knowledge and research in connected care and population health management and Banner’s deep clinical and operational insights to identify and deliver integrated solutions that are intended to improve the health of Banner’s patients.

US: Andrew Wakefield, vaccine skeptic, attends inaugural ball

Controversial vaccine skeptic Andrew Wakefieldattended one of President Trump’s inaugural balls late Friday, prompting a flood of mostly negative reaction on social media, with many commenters raising concerns that his discredited ideas will gain traction in the new administration. Wakefield, who helped launch the anti-vaccine movement with a fraudulent study linking vaccines to autism, posted a Periscope video from one of the balls, calling for an overhaul of the Centers for Disease Control and Prevention.

Yuma part of Medicare coordination experiment

As Medicare launches changes for how it pays for heart attacks and hip fractures to promote quality and contain costs, select areas such as Yuma were chosen to test these modifications. Under the revamps, doctors, hospitals and rehab centers are being encouraged to coordinate care.

Press release distribution, EDGAR filing, XBRL, regulatory filings

Senior management will host a conference c… Global Aortic Aneurysm Repair Devices Market 2017 – Forecast to 2023: Market is Expected to Grow to Reach $3,448.2 Million – Research and Markets )–Research and Markets has announced the addition of the “Aortic Aneurysm Repair Devices Global Market – Forecast to 2023” report to their offering. The Aortic Aneurysm Repai… )–Research and Markets has announced the addition of the “Global Platelet Rich Plasma Market: Trend Analysis and Forecast to 2022” report to their offering.

Report of Severe Adverse Effects of MS Drug Alemtuzumab

The multiple sclerosis therapy alemtuzumab–marketed in the United States as Lemtrada –may trigger severe, unpredictable adverse effects, according to German researchers. Writing in Lancet Neurology , the scientists report on two patients in whom the infusion of alemtuzumab significantly worsened symptoms.

Bristol-Myers Squibb stock sinks 7.2% after it says it won’t pursue…

The company said the decision was made “based on a review of the data available at this time,” and said it would say no more “in order to protect the integrity of ongoing registrational studies.” Leerink analyst Seamus Fernandez said the development was a “clear setback for BMY,” especially given a fall approval by rival drugmaker Merck in first-line lung cancer.

MSD for Mothers Commits $10 Million and Business Expertise to the…

MSD for Mothers Commits $10 Million and Business Expertise to the Global Financing Facility to Help End Preventable Deaths of Mothers MSD, known as Merck & Co., Inc., Kenilworth, N.J., U.S.A., inside the United States and Canada, announced today its $10 million commitment to the Global Financing Facility in support of Every Woman Every Child to improve maternal and child health in low- and lower-middle-income countries worldwide through its MSD for Mothers initiative.

How surgical weight loss is saving lives

Weight loss surgery is known to help people battling severe obesity lose weight, but it also saves lives by helping patients defeat diseases associated with obesity. Studies show that weight loss surgery helps resolve many weight-related health problems such as diabetes, high blood pressure, heartburn and sleep apnea, said Dr. Hamilton S. Le, medical director of the INTEGRIS Weight Loss Center.

Orthopedic Devices Market: Trend, Opportunities, Segmentation , Analysis and Forecast to 2021

WiseGuyReports.com adds “Orthopedic Devices Market 2017 Global Analysis,Growth,Trend, Opportunities Research Report Forecasting to 2021″reports to its database. PUNE, INDIA, January 13, 2017 / EINPresswire.com / — Orthopedic Devices : Summary: Orthopedic device can be defined as medical device used to replace the damaged or misplaced bone in order to improve the function of skeleton and reduce pain due to problems associated with injury/defect.

This might be how stress, heart attacks are linked

Scientists have long known that stress can influence your heart health, but exactly how this relationship takes place has been something of a mystery — until now. Activity in the amygdala, a region of the brain associated with fear and stress, can predict your risk for heart disease and stroke, according to a study published in the journal The Lancet on Wednesday.

This might be how stress and heart attacks are linked

Scientists have long known that stress can influence your heart health, but exactly how this relationship takes place has been something of a mystery – until now. Activity in the amygdala, a region of the brain associated with fear and stress, can predict your risk for heart disease and stroke, according to a study published in the journal The Lancet on Wednesday.

This Dividend Anchor Could Return More Than 23% In 2017

Pfizer has been on a roll lately, recently announcing successful top-line results for its third biosimilar in the last four months. The success of its biosimilar initiatives could potentially give Pfizer a secure foothold in the biosimilars market, which could grow to $20 billion in just three years.

For Merck, Keytruda Is ‘Extraordinarily Positive’ : More Squawk From Jim Cramer

Merck’s lung cancer treatment will get a speedy review by the FDA, but it ‘knows better than to go out and give false hope,’ TheStreet’s Jim Cramer said. Shares of Merck were higher in late morning trading Wednesday, after the company announced the U.S. Food and Drug Administration would make a decision by May 10 on its lung cancer treatment that combines the immune system-boosting drug Keytruda with chemotherapy.